Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenues $ 11,851,915 $ 6,067,853
Cost of revenues 4,041,122 2,192,812
Gross profit 7,810,793 3,875,041
Operating expenses:    
Personnel 1,339,832 737,011
Marketing and promotion 292,477 130,087
General and administrative 10,202,731 2,880,293
Goodwill writedowns 1,331,785
Total operating expenses 13,166,825 3,747,391
Operating income (5,356,032) 127,650
Non-operating expenses and (income):    
Interest expense 4,366,295 592,417
Interest income (593,214) (80,898)
Loss on debt settlements, net 4,133,481 872,133
Equity in loss of investment 43,221
Other 2,858 (226,940)
Total non-operating expenses 7,952,641 1,156,712
Net income (loss) (13,308,673) (1,029,062)
Net income (loss) attributable to noncontrolling interests 295,395 165,021
Net income (loss) attributable to MariMed Inc. $ (13,604,068) $ (1,194,083)
Net income (loss) per share $ (0.071) $ (0.010)
Weighted average common shares outstanding 192,376,020 116,275,301